Massive Bio Integrates with Oracle Cerner to Simplify Patient Records and Clinical Trial Matching

Massive Bio launches an Oracle Cerner app to simplify patient records and speed up clinical trial matching. The app empowers patients to access and compile their medical history, while providing hospitals with a tool to screen eligible patients for clinical trials. The integration with Oracle Cerner platform covers nearly two-thirds of all healthcare providers in the US, addressing a long-standing challenge in oncology: the fragmentation of patient medical data.

Massive Bio, a leading AI-powered oncology clinical trial matching company, has launched a new application that integrates with the Oracle Cerner platform to streamline patient records and expedite clinical trial matching. This integration aims to address the long-standing challenge of fragmented patient medical data in oncology, a critical issue in the United States healthcare system.

The new application, available for patients and healthcare systems using Cerner, allows patients to seamlessly connect their My Cerner Chart to their Massive Bio profile, enabling them to access and compile their comprehensive medical records with just a few clicks. This feature empowers patients to take a more active role in their healthcare journey and ensures their data is ready for analysis by Massive Bio’s advanced AI.

For healthcare providers, the application introduces a powerful bulk data retrieval feature, allowing hospitals and cancer centers using Cerner to securely and efficiently process the records of multiple consented patients at once. This functionality is designed to dramatically reduce the time and resources required for clinical trial pre-screening, enabling research teams to identify potential trial candidates on a much larger scale.

The integration with Oracle Cerner, which serves nearly two-thirds of all healthcare providers and over three-quarters of hospital capacity in the US, significantly enhances the reach and impact of Massive Bio's solutions. This extensive coverage is critical for healthcare delivery and interoperability efforts, making clinical trial enrollment more efficient and equitable.

Massive Bio’s CEO, Selin Kurnaz, stated, "Our mission is to ensure that every cancer patient has access to the best possible treatment options, and that starts with breaking down data silos." The new application is a significant step forward in achieving this goal, addressing the fragmentation of patient medical data and empowering both patients and healthcare providers.

References:
[1] https://siliconcanals.com/massive-bio-launches-oracle-cerner-app-to-simplify-patient-records-and-speed-up-clinical-trial-matching/
[2] https://www.globenewswire.com/news-release/2025/08/26/3139437/28124/en/Medical-Billing-Outsourcing-Market-Analysis-by-Type-and-Region-2025-2033.html